FDAFDA · Food and drugs·Recall number D-1257-2020
Ceftazidime for Injection USP and Dextrose for Injection USP, 2 g, 50 mL Duplex Container, RX only, B Braun Medical Inc., Bethlehem, PA 18018-3524, NDC 0264-3145-11
Published May 6, 2020 · Recall initiated: April 18, 2020
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Stability Specifications: Out-of-Specification (OOS) results for High Molecular Weight Polymers.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Manufacturer
- B. Braun Medical Inc
- Distributor
- Product was distributed nationwide within the United States.
- Lot
- Lot #: H8J812, Exp. Date 31 JUL 2020
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.